New evidence in severe pneumonia: imipenem/ cilastatin/relebactam

por Girón, Rosa Mª, Ibáñez, Amparo, Gómez-Punter, Rosa Mar, Alarcón, Teresa
Publicado 2022

Treatment of Pulmonary Disease of Cystic Fibrosis: A Comprehensive Review

por Girón Moreno, Rosa María, García-Clemente, Marta, Diab-Cáceres, Layla, Martínez-Vergara, Adrián, Martínez-García, Miguel Ángel, Gómez-Punter, Rosa Mar
Publicado 2021

Longitudinal Study of Therapeutic Adherence in a Cystic Fibrosis Unit: Identifying Potential Factors Associated with Medication Possession Ratio

por Girón, Rosa Mª, Peláez, Adrián, Ibáñez, Amparo, Martínez-Besteiro, Elisa, Gómez-Punter, Rosa Mar, Martínez-Vergara, Adrián, Ancochea, Julio, Morell, Alberto
Publicado 2022

Role of C-reactive protein as a biomarker for prediction of the severity of pulmonary exacerbations in patients with cystic fibrosis

por Girón-Moreno, Rosa Maria, Justicia, José L, Yamamoto, Sara, Valenzuela, Claudia, Cisneros, Carolina, Gómez-Punter, Rosa Mar, Fernandes-Vasconcelos, Gilda, Ancochea, Julio
Publicado 2014

Long-term safety and efficacy of tobramycin in the management of cystic fibrosis

por Vázquez-Espinosa, Emma, Girón, Rosa María, Gómez-Punter, Rosa Mar, García-Castillo, Elena, Valenzuela, Claudia, Cisneros, Carolina, Zamora, Enrique, García-Pérez, F Javier, Ancochea, Julio
Publicado 2015